Now showing items 1-7 of 7
Figure Supplemental Materials #1: Effectiveness of siRNAs knock down on targets HAS1, HAS2, UDPGD, ROBO1, and Slit2
(Oxford University Press, 2020-09-02)
Figure S1. Effectiveness of siRNAs knock down on targets HAS1, HAS2, UDPGD, ROBO1, and Slit2. Confluent fibrocyte and GD-OF cultures were transfected with control siRNA (3 µg) and respective target siRNA (3 μg) for 3 d ...
Figure Supplemental Materials #2: Relative basal and bTSH-dependent expression of hyaluronidase (Hyal) isoenzymes in fibrocytes and GF-OF
(Oxford University Press, 2020-09-02)
Figure S2. Relative basal and bTSH-dependent expression of hyaluronidase (Hyal) isoenzymes in fibrocytes and GF-OF. (A-C) Confluent cultures were incubated with DMEM supplemented with 1% FBS for 18hr, and then were untreated ...
Loss to follow-up barriers in care for Cornea Ulcers and Glaucoma: A Scoping Review Protocol
(2021-07-09)
In this scoping review, we sought to understand the barriers, both financial and nonfinancial, to accessing care for treatment of glaucoma and corneal ulcers utilizing Penchansky and Thomas’ five dimensions associated with ...
Teprotumumab divergently alters fibrocyte gene expression: Implications for thyroid-associated ophthalmopathy
(Ox ford University Press, 2022-05-23)
Context: Teprotumumab, an IGF-I receptor inhibitor (IGF-IR), is effective in thyroid-associated ophthalmopathy (TAO). The drug can modulate induction by TSH of IL-6 and IL-8 in CD34+ fibrocytes and their putative derivatives, ...
Reducing Injection-Related Safety Events in Retina Clinics
(Taylor & Francis, 2022-04-22)
Purpose: At the Kellogg Eye Center, we identified a series of injection-related patient safety events that led to a systematic review and redesign of our intravitreal injection protocol. The objective was to reduce ...